Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

GMP: Collaboration With BTS Is A Formula For Success

Summary

We present GMP as our conviction call with a BUY and raise our target price to KRW17,000.

The CICA line’s sales volume should increase as new capacity comes on stream in mid-October.

GB301, an Alzheimer’s disease medicine, is to enter phase 1 and 2a trials in Australia from December.

Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.